Low-risk gestational trophoblastic neoplasia

Five-Day Intravascular Methotrexate Versus Biweekly Actinomycin-D in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia: A Clinical Randomized Trial
Fariba Yarandi, Azamsadat Mousavi, Fereshteh Abbaslu, Soheila Aminimoghaddam, Sepideh Nekuie, Khadijeh Adabi, Parviz Hanjani

International Journal of Gynecologic Cancer Jun 2016, 26 (5) 971-976; DOI: 10.1097/IGC.0000000000000687
Response to Chemotherapy in Overweight/Obese Patients With Low-Risk Gestational Trophoblastic Neoplasia
Izildinha Maestá, Neil S. Horowitz, Donald P. Goldstein, Marilyn R. Bernstein, Luz Angela C. Ramírez, Janelle Moulder, Ross S. Berkowitz

International Journal of Gynecologic Cancer May 2015, 25 (4) 734-740; DOI: 10.1097/IGC.0000000000000398

Main menu